Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

Objective: To explore the efficacy and safety of PD-1/PD-L1 inhibitors in treating recurrent/refractory ovarian cancer (OC). Methods: The online databases, including PubMed, Embase and Cochrane Library, were searched for relevant literatures on exploring the efficacy and safety of PD-1/PD-L1 inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Siyuan, Liu, Daju, Yu, Yongai, Zou, Lei, Jin, Xianyu, Liu, Bing, Liu, Lifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042289/
https://www.ncbi.nlm.nih.gov/pubmed/36992842
http://dx.doi.org/10.3389/fphar.2023.1111061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042289/
https://www.ncbi.nlm.nih.gov/pubmed/36992842
http://dx.doi.org/10.3389/fphar.2023.1111061

Ejemplares similares